期刊文献+

针刺治疗对增生性瘢痕VEGF和血管内皮抑素的影响 被引量:8

Effect of acupuncture therapy on VEGF and endostatin in hypertrophic scar
原文传递
导出
摘要 目的探讨针刺治疗对烧伤增生性瘢痕血管内皮细胞生长因子(VEGF)和血管内皮抑素的影响。方法选择双侧肢体有对称性瘢痕增生的大面积深度烧伤康复期患者20例,梅花针针刺治疗一侧肢体,对侧常规治疗作为对照,评价针刺治疗效果。并且于治疗前、治疗后及6个月各取瘢痕组织标本,检测各组瘢痕组织中VEGF、血管内皮抑素的表达。结果与对照组比较,针刺侧瘢痕增生表现轻、VEGF表达降低(P<0.05)。结论针刺治疗对烧伤增生性瘢痕的防治作用优于常规抗瘢痕治疗,可能与针刺治疗后增生性瘢痕内VEGF表达降低有关。 Objective To study the effect of acupuncture therapy with dermal-needle on vascular endothelial growth factor(VEGF) and endostatin in hypertrophic scar(HS).MethodsTwenty HS patients on both sides of the limbs symmetrically were selected to be treated with dermal-needle on one side and conventioal treatment on the other side as the control.The efficacy of treatment was observed and compared.The expressions of VEGF and endostatin in the scars were detected by immunohistochemical method.Results Compared to the control sides,the proliferative manifestation was lighter and VEGF expression was less on the dermal-needle treating sides after treatment for three to six months(P0.05).Conclusion The efficacy of dermal-needle treatment is better than conventional therapy in preventing and treating HS,which may be ralated to a reduction of VEGF expression in hypertrophic scar.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第16期1888-1891,F0002,共5页 Jiangsu Medical Journal
关键词 增生性瘢痕 梅花针 血管内皮细胞生长因子 血管内皮抑素 Hypertrophic scar Dermal needle acupuncture Vascular endothelial growth factor Endostatin
  • 相关文献

参考文献10

  • 1徐少骏,鲍卫汉,陈东明,王琦.增殖瘢痕成纤维细胞接触后增殖及生物合成特性对异常瘢痕形成的机理[J].中华整形外科杂志,2002,18(2):86-88. 被引量:19
  • 2Steinbrech DS, Longaker MT, Mehrara BJ, et al. Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation[J]. J Surg Res, 1999,84(2) :127-133.
  • 3Yamagishi S, Yonekura H, Yamamoto Y, et al. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic condition[J].Lab Invest, 1999,79 (4) : 501-509.
  • 4Mohanraj D, Ramani R, Matthew JF, et al. Endostatin induces,endostatin cell apoptosis[J]. J Bio Chem, 1999, 274 (17) : 11721-11726.
  • 5O'Relly MS, Boehrn T, Shing Y, et al. Endostatin : an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2) :277-285.
  • 6Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J]. Nature, 1997,390(6658) : 404-407.
  • 7Perletti A, Concari P, Gardini R, et al. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors[J]. Cancer Res, 2000,60 (7) : 1793-1796.
  • 8Blezinger P, Wang J, Condo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene[J]. Nat Biotechnol, 1999,17 (4):343-348.
  • 9Bertolini F, Fusetti L, Mancuso P, et al. Endostatin, anantiangiogenic drug,induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non Hodgkin lymphoma [J]. Blood, 2000, 96 ( 1 ) : 282 -287.
  • 10Berger AC, Feldman AL, Gnant MF,et al. The angiogenesis inhabitor, endostatin, does not affect murine cutaneous wound healing[J]. J Surg Res, 2000,91 (1) : 26-31.

二级参考文献8

  • 1Keiman Z.PCNA:structure,functions and interaction.Oncogene,1997,14:629-640.
  • 2Bravo R,Frank R.Cycline/PCNA is the auxiliary protein of DNA polymerase.Nature,1987,326:515-517.
  • 3Xiong Y,Zhang H,Beach D.Subunit rearrangement of the cyclin-dependent kinase is associated with cellular transformation.Genes Dev, 1993,7:1572-1583.
  • 4Lukas J,Parry D,Aagaad L,et al.Retioblastoma protein-dependent cell-cycle inhibition by tumor suppressor P16.Nature,1995,375:503-506.
  • 5Krieg T.Collagen in the healing wound.Wounds,1995,T(suppl A):A5-A12.
  • 6Zhang LQ,Laato M,Muona P,et al.Normal and hypertrophic scars-quantification and localization of mRNAs for type Ⅰ,Ⅲ and Ⅵ collagens.Br J Dermatol,1994,130:453-459.
  • 7David WF,Charles DB,James WM,et al.Regulation of collagen gene expression in keloids and hypertrophic scars.J Surg Res,1993,55:214-222.
  • 8徐少骏,王志刚,鲍卫汉.瘢痕疙瘩和正常皮肤成纤维细胞对白介素-1β和白介素-6的反应[J].中华整形烧伤外科杂志,1998,14(1):23-25. 被引量:18

共引文献18

同被引文献134

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部